Press Releases

» Auto updated continuously

 2018-07-23 06:56 

PR Newswire

OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing...
 2018-07-23 06:42 

PR Newswire

OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing...

OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing...

 2018-07-23 06:40 

PR Newswire

Singtel and Ericsson to Launch Singapore's First 5G Pilot Network...

Singtel and Ericsson to Launch Singapore's First 5G Pilot Network...

 2018-07-23 06:37 

PR Newswire

No Toxicity Seen in Mice as Regen BioPharma, Inc. Finishes Initial Optimization of its Lead NR2F6 Small Molecule Agonist...
 2018-07-23 06:33 

PR Newswire

Universal Power Industry Corporation's Play Market Unit Receives Additional Purchase Order...
 2018-07-23 06:32 

GlobeNewswire

UIE's share buy-back programme...

On 6 March 2018, UIE announced two parallel share buy-back programmes; A Safe Harbour programme and a block trade programme. Both programmes were initiated with the purpose of reducing the share capital, cf. Company Announcement No. 6/2018. Please find en...

 2018-07-23 06:32 

GlobeNewswire

UIE's aktietilbagekbsprogram...

Den 6. marts 2018 igangsatte UIE to parallelle aktietilbagekbsprogrammer; et "Safe Harbour"-program og et "Block trade"-program. Begge programmer blev sat i gang med det forml at reducere selskabets aktiekapital, jf. Selskabsmeddelelse nr....

 2018-07-23 06:30 

PR Newswire

Sangamo Therapeutics to Acquire TxCell...

The Proposed Acquisition Would Combine Sangamo's Ex Vivo Gene Editing Capabilities and TxCell's Treg Expertise and Would Position Sangamo as a Leader in CAR-Treg Development,Initiation of First CAR-Treg Clinical Trial Expected in 2019...

 2018-07-23 06:30 

PR Newswire

AGORA Images Closes 2 Million Euro Financing Round...
 2018-07-23 06:30 

PR Newswire

AGORA Images Closes 2 Million Euro Financing Round...

Press Releases
• Sources this section: BusinessWire, GlobeNewswire, Marketwire, NewsLookup.com and PR Newswire

  • Need an account?  
    or